FDA Import Refusal 231-9994206-6/20002/1 — Intas Pharmaceuticals Limited
The FDA refused shipment 231-9994206-6/20002/1 from Intas Pharmaceuticals Limited (India) on Aug 4, 2026. The refused product falls under Drugs and Biologics — NALTREXONE (ANTAGONIST). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 4, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60TCA15 NALTREXONE (ANTAGONIST)
- Charges
- 27